ENDOCRINE JOURNAL, published by the Japan Endocrine Society, is a pivotal resource for researchers and professionals in the field of endocrinology, diabetes, and metabolism. With a long history dating back to 1954, this journal encompasses a comprehensive range of topics including hormonal regulation, pathophysiology of endocrine diseases, and innovative therapeutic approaches. Despite its classification as open access, the journal remains a beacon of knowledge, with impressive rankings—Q2 in Endocrinology, Diabetes and Metabolism and Q3 in Endocrinology for 2023—ensuring it is a respected source in the academic community. It serves as a critical platform for the dissemination of cutting-edge research, encouraging collaboration and facilitating advancements in understanding complex endocrine disorders. By subscribing to this journal, researchers and students gain access to seminal studies, clinical insights, and a wealth of information that drives this vital field forward.

TRENDS IN ENDOCRINOLOGY AND METABOLISM, published by CELL PRESS, stands as a pivotal resource in the fields of endocrinology, diabetes, and metabolism. With its ISSN 1043-2760 and E-ISSN 1879-3061, this esteemed journal has been a leading platform since its inception in 1989, currently projected to span until 2024. Recognized within the top quartile (Q1) of its category, it boasts impressive Scopus rankings, holding the 4th position in Endocrinology and 8th in Endocrinology, Diabetes, and Metabolism. These rankings underscore its significant impact, evidenced by an impressive percentile rank of 97th and 96th respectively. The journal is committed to facilitating the dissemination of cutting-edge research and innovative insights, making it an essential read for researchers, clinicians, and students seeking to stay informed on the latest advancements in these critical fields. With a robust focus on providing thorough reviews and original research articles, TRENDS IN ENDOCRINOLOGY AND METABOLISM continues to shape the understanding and treatment of metabolic disorders.

Frontiers in Endocrinology, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the advancement of research in the fields of endocrinology, diabetes, and metabolism. Established in 2010, this journal has consistently demonstrated its academic excellence, achieving a prominent Q1 quartile ranking in its category as of 2023, and a commendable Scopus rank of #96 out of 244, placing it within the 60th percentile. The journal is committed to disseminating high-quality research that encompasses a wide range of topics within endocrinology, catering to the needs of a diverse audience that includes researchers, medical professionals, and students alike. With the critical goal of fostering knowledge-sharing and collaboration within the scientific community, Frontiers in Endocrinology is an invaluable resource for anyone looking to stay updated on the latest advancements and insights in endocrinology. It operates under a robust open-access model, ensuring that groundbreaking research is accessible to all, thereby driving innovation and progress in this essential field.

Journal of Medical Biochemistry is a distinguished peer-reviewed journal published by the SOC MEDICAL BIOCHEMISTS SERBIA, focusing on the significant intersection of biochemistry and medicine. With an e-ISSN of 1452-8266, this Open Access journal has been enriching the academic community since 2007, providing vital insights and research findings that advance the field of medical biochemistry. Based in Belgrade, Serbia, the journal plays a pivotal role in disseminating contemporary research, highlighted by its impressive standings in the 2023 quartile rankings, featuring Q2 in Medical Biochemistry and Q3 in Clinical Biochemistry. The journal is recognized in Scopus with rankings that position it within the discerning area of medical biochemistry and clinical biochemistry, attesting to its influence and relevance. By promoting innovative research and facilitating an open exchange of scientific ideas, the Journal of Medical Biochemistry is a crucial resource for researchers, professionals, and students dedicated to uncovering the biochemical underpinnings essential to improving human health.

PTERIDINES is a unique journal dedicated to the study of pteridines and their implications in biochemistry and clinical research. Published by DE GRUYTER POLAND SP Z O O, this Open Access journal has been a vital resource since its inception in 1989, steadily evolving to include a diverse range of topics pertinent to molecular medicine and biochemistry. With its current classification in the Q4 quartile for Biochemistry, Clinical Biochemistry, and Molecular Medicine, PTERIDINES offers a platform for researchers and professionals seeking to disseminate and access groundbreaking findings. Although the journal has a modest Scopus ranking, it serves as an important outlet for both emerging and established scholars in the field, particularly those focusing on the biochemical roles of pteridines. Based in Germany, the journal invites contributions from around the globe, providing equitable access to all readers since 2018, making significant strides towards inclusive scientific discourse. As such, PTERIDINES is a valuable asset for anyone engaged in the exploration of pteridines and their multifaceted roles in health and disease.

Welcome to Critical Reviews in Biochemistry and Molecular Biology, a premier academic journal published by Taylor & Francis Ltd, dedicated to advancing the fields of biochemistry and molecular biology. With an impressive impact factor and a Q1 ranking in both Biochemistry and Molecular Biology for 2023, this journal serves as a vital resource for researchers, professionals, and students eager to engage with cutting-edge reviews and analyses that synthesize the latest developments in these dynamic areas of study. Since its inception in 1972, the journal has maintained a commitment to high-quality scholarship, providing a platform for critical discussions that accelerate the discovery and understanding of biochemical processes and molecular interactions. Although not open access, its robust editorial peer-review process ensures that published articles meet the highest standards of scientific rigor, making it a trusted source for the scientific community. As we continue to converge toward 2024, we invite you to explore the extensive array of topics and findings that have shaped contemporary biochemistry and molecular biology.

MAGNESIUM RESEARCH, published by John Libbey Eurotext Ltd, is a leading journal in the fields of biochemistry, clinical biochemistry, and molecular biology, dedicated to advancing the understanding of magnesium's role in biological systems. With an ISSN of 0953-1424 and an E-ISSN of 1952-4021, this journal has been a vital resource for researchers and professionals since its inception in 1988, now converging into its 2024 issues. Positioned in the Q4 category for 2023 across several biochemistry domains, the journal is indexed in Scopus, providing a significant platform for the dissemination of research findings. Despite its current rankings reflecting a need for further impact, the journal serves as an important venue for emerging research that explores the biochemical and metabolic functions of magnesium, underlining its crucial influence on health and disease. Although primarily published using traditional access models, the content remains relevant for those seeking to deepen their knowledge in this essential mineral’s biological importance. Researchers, students, and professionals in related fields will find MAGNESIUM RESEARCH an invaluable addition to their academic resources.

HORMONE AND METABOLIC RESEARCH, published by GEORG THIEME VERLAG KG, stands as a reputable platform in the fields of biochemistry, endocrinology, and metabolism since its establishment in 1969. This peer-reviewed journal provides critical insights and advancements in the intricate relationships between hormones and metabolic processes, catering to researchers, healthcare professionals, and students alike. With an impressive convergence of knowledge spanning over five decades, it maintains a commendable Q3 ranking in multiple categories, including Biochemistry, Clinical Biochemistry, and Endocrinology, highlighting its contribution to cutting-edge scientific discourse. Although not an open-access journal, it offers a plethora of access options for readers and institutions, ensuring that vital research reaches those who need it most. Located in Stuttgart, Germany, the journal is positioned at the forefront of influential research in hormone and metabolic studies, emphasizing its importance for ongoing investigations into health and disease.

Journal of Biochemistry, published by Oxford University Press, is a prestigious academic journal that has been at the forefront of biochemical research since its inception in 1922. With an ISSN of 0021-924X and an E-ISSN of 1756-2651, this journal serves as a platform for disseminating high-quality research in the fields of biochemistry, molecular biology, and medicine, holding impressive rankings such as Q2 in Biochemistry and Medicine (miscellaneous) in 2023. As of 2024, the journal continues to explore significant topics in these areas, offering valuable insights for researchers, professionals, and students alike. The journal does not currently offer open access, but it remains a vital resource for anyone in the biochemical community seeking to stay updated on the latest discoveries and advancements. With its rich history and dedication to scientific excellence, the Journal of Biochemistry is an indispensable part of the scholarly landscape.

FEBS LETTERS, published by Wiley, is a prestigious journal that has firmly established its place in the fields of biochemistry, biophysics, genetics, molecular biology, cell biology, and structural biology. With an esteemed history dating back to 1968, this journal continues to be a vital resource for researchers and professionals involved in the biological sciences. It boasts impressive quartile rankings, including Q1 statuses in several categories such as Biochemistry and Genetics, reflecting its high impact factor and significant contribution to scientific discourse. FEBS LETTERS provides a platform for innovative findings and critical reviews, fostering the exchange of knowledge and ideas within the scientific community. Although it operates under a subscription model, the journal ensures broad dissemination of groundbreaking research through its rigorous peer-review process. The vibrant discussions encouraged by articles published in FEBS LETTERS aim to inspire current and future generations of scientists to push the boundaries of biological understanding, making it an indispensable resource for anyone dedicated to advancing their knowledge in these dynamic fields.